Compare Lustrum:OncoTherapy Science,Inc.:4564

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index OncoTherapy Science,Inc. Go to web site 4564 Medicals 東証グロース March 1, 2000 2003.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

OncoTherapy Science,Inc. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

OncoTherapy Science,Inc. Balance Sheet 2025年3月期 OncoTherapy Science,Inc. Balance Sheet 2024年3月期 OncoTherapy Science,Inc. Balance Sheet 2023年3月期 OncoTherapy Science,Inc. Balance Sheet 2022年3月期 OncoTherapy Science,Inc. Balance Sheet 2021年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Cash and Cash Equivalents
(Percent)
834up
(72.2%)up
528down
(60.8%)down
1,118down
(73.9%)up
1,837down
(68.4%)down
2,899
(86.1%)
Other Current AssetsHelp
(Percent)
272down
(23.5%)down
290down
(33.5%)up
305down
(20.2%)down
764up
(28.4%)up
295
(8.8%)
Tangible Fixed AssetsHelp
(Percent)
0
-
0
-
0
-
0down
(0.0%)down
95
(2.8%)
Intangible Fixed AssetHelp
(Percent)
0
-
0
-
0
-
0
-
5
(0.1%)
Investments and OthersHelp
(Percent)
50
(4.3%)down
50down
(5.7%)down
89up
(5.9%)up
85up
(3.2%)up
74
(2.2%)
Total AssetsHelp
(Percent)
1,155
(100%)
867
(100%)
1,511
(100%)
2,685
(100%)
3,368
(100%)
Total Current LiabilitiesHelp
(Percent)
375down
(32.5%)down
407down
(46.9%)up
656down
(43.4%)up
705up
(26.3%)up
291
(8.6%)
Total Long-term LiabilitiesHelp
(Percent)
51down
(4.4%)down
107
(12.3%)
0
-
0
-
0
-
Shareholder's EquityHelp
(Percent)
729up
(63.1%)up
354down
(40.8%)down
855down
(56.6%)down
1,980down
(73.7%)down
3,077
(91.4%)
Total LiabilitiesHelp
(Percent)
1,155
(100%)
867
(100%)
1,511
(100%)
2,685
(100%)
3,368
(100%)

OncoTherapy Science,Inc. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

OncoTherapy Science,Inc. Profit and Loss Account 2025年3月期 OncoTherapy Science,Inc. Profit and Loss Account 2024年3月期 OncoTherapy Science,Inc. Profit and Loss Account 2023年3月期 OncoTherapy Science,Inc. Profit and Loss Account 2022年3月期 OncoTherapy Science,Inc. Profit and Loss Account 2021年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Amount of Sales
(Percent)
750
(100%)
610
(100%)
1,135
(100%)
1,154
(100%)
332
(100%)
Total Sales
(Percent)
750
(100%)
610
(100%)
1,135
(100%)
1,154
(100%)
332
(100%)
Cost of SalesHelp
(Percent)
763down
(101.7%)down
788down
(129.1%)up
1,093up
(96.3%)up
1,040up
(90.1%)down
313
(94.1%)
Other Costs and RevenueHelp 803down
(107.0%)down
1,110down
(182.0%)up
1,160down
(102.2%)down
2,685up
(232.8%)down
1,581
(475.6%)
Total CostsHelp 1,565 1,898 2,254 3,725 1,894
Net RevenueHelp -13up
(-1.7%)up
-178down
(-29.1%)down
42down
(3.7%)down
114up
(9.9%)up
20
(5.9%)
Earnings Before TaxHelp -813up
(-108.4%)up
-1,286down
(-210.7%)down
-1,116up
(-98.4%)up
-2,570down
(-222.8%)up
-1,560
(-469.2%)
Net IncomeHelp -815up
(-108.7%)up
-1,288down
(-211.1%)down
-1,119up
(-98.6%)up
-2,572down
(-222.9%)up
-1,562
(-469.7%)
当期純利益 -815 -1,288 -1,119 -2,572 -1,562

OncoTherapy Science,Inc. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

OncoTherapy Science,Inc. Cash Flow Statement 2025年3月期 OncoTherapy Science,Inc. Cash Flow Statement 2024年3月期 OncoTherapy Science,Inc. Cash Flow Statement 2023年3月期 OncoTherapy Science,Inc. Cash Flow Statement 2022年3月期 OncoTherapy Science,Inc. Cash Flow Statement 2021年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Operating Cash Flow(OFC)Help
(Percent)
-815up
(-72.7%)up
-1,228down
(-97.4%)up
-795up
(-97.5%)down
-2,073down
(-81.6%)down
-1,763
(-53.5%)
Investing Cash Flow(ICF)Help
(Percent)
-0up
(0.0%)up
-33down
(-2.6%)down
-20up
(-2.5%)up
-468down
(-18.4%)down
-52
(-1.6%)
Financing Cash FlowHelp
(Percent)
1,122up
(100.0%)up
671up
(53.2%)up
96down
(11.8%)down
1,479
(58.2%)up
1,479
(44.9%)
Exchange Difference of Cash and Cash EquivalentsHelp
(Percent)
-0down
(0.0%)down
0up
(0.0%)down
0
(0.0%)
0
-
-1,479
(-44.9%)
Net Increase and Decrease in Cash and Cash Equivalentsn 306up
(27.3%)up
-590up
(-46.8%)up
-719up
(-88.2%)down
-1,062up
(-41.8%)up
-1,815
(-55.1%)

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

OncoTherapy Science,Inc.
Last One Mile Co.,Ltd.

Company where related level is highHelp

Sumitomo Pharma Co., Ltd.
Noile-Immune Biotech Inc.
Perseus Proteomics Inc.
LTT Bio-Pharma Co.,Ltd.
CHUKYOIYAKUHIN CO.,LTD.
PeptiDream Inc.
TAISHO PHARMACEUTICAL CO.,LTD.
ASKA Pharmaceutical Holdings Co., Ltd.
MUROMACHI CHEMICALS INC.
TMS Co.,Ltd.